24
Mar

Gilead won the race to be the first to market with an interferon-free oral therapy that can essentially wipe out all traces of the virus for a large group of patients. Now it’s angling to follow up that big score with a single combo pill that can do the job for just about everyone in the megablockbuster market.

…read more

Source: Gilead scrambles toward hep C cure-all with next-gen combo pill

    

0 No comments